GGrantIndex
← Leaderboards

Paula M Pitha-Rowe

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$8,862,652
Attributed
$8,862,652
Total exposure
11
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $763.5K · FY2005–10
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$8,862,652 · 11

By mechanism

R01$4,249,349 · 3
T32$2,572,633 · 1
R21$1,553,469 · 4
R37$323,701 · 1
R03$163,500 · 1
P01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Interferons”

Research focus

InterferonsMacrophageApoptosisGene ExpressionTranscription FactorLaboratory MouseNewcastle Disease VirusDna Binding ProteinGenetic Promoter ElementGenetic TranscriptionProtein Structure FunctionCytokineInflammationDendritic CellsMicroorganism ImmunologyBiologicalBinding ProteinsAntiviral AgentsB-Cell LymphomasCell GrowthBaseAnti-Bacterial AgentsAssesCd4 Positive T Lymphocytes

Grant awards (33)

Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$386,641
R01 · FY2010 · AI · contact PI
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$139,974
R01 · FY2010 · AI · contact PI
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$390,546
R01 · FY2009 · AI · contact PI
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$38,048
R01 · FY2009 · AI · contact PI
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$390,546
R01 · FY2008 · AI · contact PI
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$398,110
R01 · FY2007 · AI · contact PI
Innate antiviral response and predisposition to neoplasia in IRF-5 deficient mous$408,750
R01 · FY2006 · AI · contact PI
Role of Novel Factor IRF-5 in Innate Immunity$279,402
R01 · FY2006 · AI · contact PI
Molecular Targets for Cancer Detection and Treatment$477,405
T32 · FY2005 · CA
Role of Novel Factor IRF-5 in Innate Immunity$286,125
R01 · FY2005 · AI
Molecular Targets for Cancer Detection and Treatment$464,808
T32 · FY2004 · CA
Role of Novel Factor IRF-5 in Innate Immunity$286,125
R01 · FY2004 · AI
Cellular Response to Infectious Triggers$245,250
R21 · FY2004 · AI
Role of IRFs in the Innate Response to HIV$245,250
R21 · FY2004 · AI
Molecular Targets for Cancer Detection and Treatment$433,633
T32 · FY2003 · CA
Role of Novel Factor IRF-5 in Innate Immunity$286,125
R01 · FY2003 · AI
Role of IRFs in the Innate Response to HIV$245,250
R21 · FY2003 · AI
Cellular Response to Infectious Triggers$245,250
R21 · FY2003 · AI
Stimulation of DNA vaccines by IRF$81,750
R03 · FY2003 · AI
Molecular Targets for Cancer Detection and Treatment$414,383
T32 · FY2002 · CA
Role of Novel Factor IRF-5 in Innate Immunity$214,594
R01 · FY2002 · AI
Stimulation of DNA vaccines by IRF$81,750
R03 · FY2002 · AI
HHV-8IRF-2 and IRF-3 genes$0
P01 · FY2002 · CA
Molecular Targets for Cancer Detection and Treatment$413,715
T32 · FY2001 · CA
Activation of Early Inflammatory Genes$286,344
R21 · FY2001 · AI
Role of Transcription Factor IRF-5 in Infected Cells$286,125
R21 · FY2001 · AI
CRITICAL ROLE OF HHV8 ENCODED IRF IN AIDS LYMPHOMAS$253,047
R01 · FY2001 · CA
HHV-8IRF-2 and IRF-3 genes$0
P01 · FY2001 · CA
ONCOLOGY CHEMOTHERAPY IMMUNOLOGY BIOLOGY$368,689
T32 · FY2000 · CA
CYTOKINES AND THE PATHOGENESIS OF AIDS$323,701
R37 · FY2000 · AI
CRITICAL ROLE OF HHV8 ENCODED IRF IN AIDS LYMPHOMAS$246,967
R01 · FY2000 · CA
VIRUS/IFN INDUCED SIGNALING PATHWAY IN PATHOGENICITY$244,349
R01 · FY2000 · AI
HHV-8IRF-2 and IRF-3 genes$0
P01 · FY2000 · CA